Grand Rounds is focused on reducing high cost claimants and improving patient outcomes and we have tangible evidence to prove it……………………
We begin another “Data Insights” series from Grand Rounds, and this time specific to MSK & Cancer. Over the next few months I will be sending you interesting outcome analytic data on these two conditions.
As you know, Grand Rounds is focused on reducing high cost claimants and improving patient outcomes and we have tangible evidence to prove it. Why and how do we do this?
Why: Musculoskeletal conditions drive the highest spend for organizations, by far. According to NBGH, half of adult Americans will face MSK issues, making up 18% of all health visits, with the average annual cost being $7,800 per person for treatment.
How: That’s a lot of uncertainty and risk for employers. Our solutions address MSK through:
- Maximize conservative treatment
- Cancel unnecessary surgeries
- Improve surgical outcomes
- Reduce opioid exposure
Are any of your clients facing high cost MSK conditions that need a solution? Let me hear your comments and we would love to share our approach and the success stories some of our employer clients are seeing.
Hear from a Schwan’s employee how Grand Rounds helped his MSK issue
Kimberlee Walters | Mid-Market Sales Director, SW Region
Grand Rounds – Dallas
Direct: 214-232-0799
Email: kimberlee.walters@grandrounds.com
Important Links for your review:
Should Big Data Pick Your Next Doctor? Read this recent article about our founder in Forbes
How We’re Helping Folks Like Stacey and Jordan (video) access the top 1% of health care.
